ESC Premium Access

Futility risk model development and validation among patients with aortic stenosis treated with transcatheter aortic valve replacement

Congress Presentation

About the speaker

Doctor Arnaud Bisson

CHU de Tours, Tours (France)
0 follower

9 more presentations in this session

Impact of surgery for mitral regurgitation at the time of aortic valve replacement

Speaker: Doctor N. Kato (Urayasu, JP)


Peripheral vascular access for transcatheter aortic valve implantation: transcarotid versus femoral access

Speaker: Professor T. Folliguet (Creteil, FR)


The outcome of TAVI in patients with small annulus and the comparison between intra-annular and supra-annular devices in small anulus: From the analysis of the Japanese nationwide registry

Speaker: Doctor K. Meguro (Kanagawa, JP)


Outcomes of different approaches for severe aortic stenosis: "The Deferred-TAVI", a multicentre study investigating medical and percutaneous therapy in the era of TAVI

Speaker: Doctor F. Bruno (Turin, IT)


TAVI is associated with less patient-prosthesis-mismatch than surgical aortic valve repair of severe aortic stenosis: A systematic review and meta-analysis

Speaker: Associate Professor C. Abi Khalil (Doha, QA)


Access the full session

Poster Session 2 - Transcatheter aortic interventions

Speakers: Doctor A. Bisson, Doctor N. Kato, Professor T. Folliguet, Doctor K. Meguro, Doctor F. Bruno...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb